Literature DB >> 28375931

A Comparison of the Detection of Sentinel Lymph Nodes Using Indocyanine Green and Near-Infrared Fluorescence Imaging Versus Blue Dye During Robotic Surgery in Uterine Cancer.

Ane Gerda Eriksson1, Anna Beavis, Robert A Soslow, Qin Zhou, Nadeem R Abu-Rustum, Ginger J Gardner, Oliver Zivanovic, Kara Long Roche, Yukio Sonoda, Mario M Leitao, Elizabeth L Jewell.   

Abstract

OBJECTIVES: The objective of this study was to assess and compare the sentinel lymph node (SLN) detection rate with indocyanine green (ICG) and near-infrared fluorescence imaging versus blue dye using the robotic platform in patients with uterine cancer.
METHODS: We identified all patients with uterine cancer undergoing SLN mapping using ICG or blue dye on the robotic platform from January 2011 to December 2013. Our institutional SLN algorithm and pathologic processing protocol were adhered to uniformly. We compared detection rates of SLNs stratified by dye used. Appropriate statistical tests were used.
RESULTS: A total of 472 patients were identified. ICG was used in 312 patients (66%) and blue dye in 160 patients (34%). Successful mapping was achieved in 425 (90%) of 472 patients. Mapping was bilateral in 352 patients (75%) and unilateral in 73 patients (15%); 47 patients (10%) did not map. Successful mapping was achieved in 295 (95%) of 312 patients using ICG compared with 130 (81%) of 160 patients using blue dye (P < 0.001). Mapping was bilateral in 266 (85%) of 312 patients in the ICG group compared with 86 (54%) of 160 in the blue dye group (P < 0.001). Additional lymph node dissection beyond removal of the SLNs was performed in 122 patients (39%) mapped with ICG compared with 98 patients (61%) mapped with blue dye (P < 0.001).
CONCLUSIONS: The SLN detection rate was superior when mapping with ICG rather than blue dye. Bilateral mapping was significantly improved, resulting in a lower rate of additional lymphadenectomy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28375931      PMCID: PMC5404984          DOI: 10.1097/IGC.0000000000000959

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  14 in total

1.  Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer.

Authors:  J How; W H Gotlieb; J Z Press; J Abitbol; M Pelmus; A Ferenczy; S Probst; R Gotlieb; S Brin; S Lau
Journal:  Gynecol Oncol       Date:  2015-04-12       Impact factor: 5.482

2.  The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes.

Authors:  Nadeem R Abu-Rustum; Jacob D Gomez; Kaled M Alektiar; Robert A Soslow; Martee L Hensley; Mario M Leitao; Ginger J Gardner; Yukio Sonoda; Dennis S Chi; Richard R Barakat
Journal:  Gynecol Oncol       Date:  2009-08-09       Impact factor: 5.482

3.  Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery.

Authors:  Ane Gerda Zahl Eriksson; Margaret Montovano; Anna Beavis; Robert A Soslow; Qin Zhou; Nadeem R Abu-Rustum; Ginger J Gardner; Oliver Zivanovic; Richard R Barakat; Carol L Brown; Douglas A Levine; Yukio Sonoda; Mario M Leitao; Elizabeth L Jewell
Journal:  Ann Surg Oncol       Date:  2016-02-23       Impact factor: 5.344

4.  The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes.

Authors:  Joyce N Barlin; Fady Khoury-Collado; Christine H Kim; Mario M Leitao; Dennis S Chi; Yukio Sonoda; Kaled Alektiar; Deborah F DeLair; Richard R Barakat; Nadeem R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2012-02-22       Impact factor: 5.482

5.  Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).

Authors:  Marcos Ballester; Gil Dubernard; Fabrice Lécuru; Denis Heitz; Patrice Mathevet; Henri Marret; Denis Querleu; François Golfier; Eric Leblanc; Roman Rouzier; Emile Daraï
Journal:  Lancet Oncol       Date:  2011-04-12       Impact factor: 41.316

6.  Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies.

Authors:  Elizabeth L Jewell; Juan Juan Huang; Nadeem R Abu-Rustum; Ginger J Gardner; Carol L Brown; Yukio Sonoda; Richard R Barakat; Douglas A Levine; Mario M Leitao
Journal:  Gynecol Oncol       Date:  2014-02-28       Impact factor: 5.482

7.  Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging.

Authors:  Christine H Kim; Robert A Soslow; Kay J Park; Emma L Barber; Fady Khoury-Collado; Joyce N Barlin; Yukio Sonoda; Martee L Hensley; Richard R Barakat; Nadeem R Abu-Rustum
Journal:  Int J Gynecol Cancer       Date:  2013-06       Impact factor: 3.437

8.  A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer.

Authors:  Abdulrahman K Sinno; Amanda Nickles Fader; Kara Long Roche; Robert L Giuntoli; Edward J Tanner
Journal:  Gynecol Oncol       Date:  2014-06-02       Impact factor: 5.482

9.  Update on sentinel node mapping in uterine cancer: 10-year experience at Memorial Sloan-Kettering Cancer Center.

Authors:  Nadeem R Abu-Rustum
Journal:  J Obstet Gynaecol Res       Date:  2014-02       Impact factor: 1.730

10.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

View more
  11 in total

Review 1.  Surgical staging in endometrial cancer.

Authors:  Maria Luisa Gasparri; Donatella Caserta; Pierluigi Benedetti Panici; Andrea Papadia; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2018-11-20       Impact factor: 4.553

Review 2.  Sentinel lymph node mapping in endometrial cancer: comparison of fluorescence dye with traditional radiocolloid and blue.

Authors:  Andrea Papadia; Maria Luisa Gasparri; Alessandro Buda; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-21       Impact factor: 4.553

3.  Sentinel lymph node biopsy alone compared to systematic lymphadenectomy in patients with uterine carcinosarcoma.

Authors:  William A Zammarrelli; Michelle Greenman; Eric Rios-Doria; Katie Miller; Vance Broach; Jennifer J Mueller; Emeline Aviki; Kaled M Alektiar; Robert A Soslow; Lora H Ellenson; Vicky Makker; Nadeem R Abu-Rustum; Mario M Leitao
Journal:  Gynecol Oncol       Date:  2022-02-26       Impact factor: 5.304

4.  Sentinel lymph node biopsy in patients with endometrial cancer and an indocyanine green or iodinated contrast reaction - A proposed management algorithm.

Authors:  William A Zammarrelli; Anoushka M Afonso; Vance Broach; Yukio Sonoda; Oliver Zivanovic; Jennifer J Mueller; Mario M Leitao; Amelia Chan; Nadeem R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2021-05-13       Impact factor: 5.304

5.  The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells.

Authors:  Sanchareeka Dey; Sharda Kumari; Sarada Preeta Kalainayakan; James Campbell; Poorva Ghosh; Heling Zhou; Keely E FitzGerald; Maoping Li; Ralph P Mason; Li Zhang; Li Liu
Journal:  Oncotarget       Date:  2017-12-28

6.  Status of Sentinel Lymph Node Biopsy in Endometrial Cancer.

Authors:  Florin Andrei Taran; Lisa Jung; Julia Waldschmidt; Sarah Isabelle Huwer; Ingolf Juhasz-Böss
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-05-20       Impact factor: 2.915

Review 7.  Recent Developments of ICG-Guided Sentinel Lymph Node Mapping in Oral Cancer.

Authors:  Ji-Hoon Kim; Minhee Ku; Jaemoon Yang; Hyung Kwon Byeon
Journal:  Diagnostics (Basel)       Date:  2021-05-17

8.  Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.

Authors:  Hans Nagar; Nina Wietek; Richard J Goodall; Will Hughes; Mia Schmidt-Hansen; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2021-06-09

9.  Role of Indocyanine Green in Fluorescence Imaging with Near-Infrared Light to Identify Sentinel Lymph Nodes, Lymphatic Vessels and Pathways Prior to Surgery - A Critical Evaluation of Options.

Authors:  Andreas Hackethal; Markus Hirschburger; Sven Oliver Eicker; Thomas Mücke; Christoph Lindner; Olaf Buchweitz
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-01-22       Impact factor: 2.915

Review 10.  A practical guide for the use of indocyanine green and methylene blue in fluorescence-guided abdominal surgery.

Authors:  Labrinus van Manen; Henricus J M Handgraaf; Michele Diana; Jouke Dijkstra; Takeaki Ishizawa; Alexander L Vahrmeijer; Jan Sven David Mieog
Journal:  J Surg Oncol       Date:  2018-06-24       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.